Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploring protein hotspots by optimized fragment pharmacophores
Dávid Bajusz, Warren S. Wade, Grzegorz Satała, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents
Ying Zhou, Yintao Zhang, Xichen Lian, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D1398-D1407
Open Access | Times Cited: 501
Fragment‐based drug discovery—the importance of high‐quality molecule libraries
Marta Bon, Alan Bilsland, Justin Bower, et al.
Molecular Oncology (2022) Vol. 16, Iss. 21, pp. 3761-3777
Open Access | Times Cited: 76
Fragment-to-Lead Medicinal Chemistry Publications in 2021
Louise Walsh, Daniel A. Erlanson, Iwan J. P. de Esch, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 2, pp. 1137-1156
Open Access | Times Cited: 35
Ultrafast Fragment Screening Using Photo-Hyperpolarized (CIDNP) NMR
Felix Torres, Matthias Bütikofer, Gabriela R. Stadler, et al.
Journal of the American Chemical Society (2023) Vol. 145, Iss. 22, pp. 12066-12080
Open Access | Times Cited: 32
Fragment-based drug discovery supports drugging ‘undruggable’ protein–protein interactions
Zhi-Zheng Wang, Xing-Xing Shi, Guang-Yi Huang, et al.
Trends in Biochemical Sciences (2023) Vol. 48, Iss. 6, pp. 539-552
Closed Access | Times Cited: 26
High-Throughput Activity Assay for Screening Inhibitors of the SARS-CoV-2 Mac1 Macrodomain
Morgan Dasovich, Junlin Zhuo, Jack A. Goodman, et al.
ACS Chemical Biology (2021) Vol. 17, Iss. 1, pp. 17-23
Open Access | Times Cited: 42
The Conserved Macrodomain Is a Potential Therapeutic Target for Coronaviruses and Alphaviruses
Anthony K. L. Leung, Diane E. Griffin, Jürgen Bosch, et al.
Pathogens (2022) Vol. 11, Iss. 1, pp. 94-94
Open Access | Times Cited: 32
Medicinal chemistry strategies towards the development of non-covalent SARS-CoV-2 Mpro inhibitors
Letian Song, Shenghua Gao, Bing Ye, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 14, Iss. 1, pp. 87-109
Open Access | Times Cited: 20
NMR Spectroscopy of the Main Protease of SARS‐CoV‐2 and Fragment‐Based Screening Identify Three Protein Hotspots and an Antiviral Fragment
François‐Xavier Cantrelle, Emmanuelle Boll, Lucile Brier, et al.
Angewandte Chemie International Edition (2021) Vol. 60, Iss. 48, pp. 25428-25435
Open Access | Times Cited: 35
Fragment Libraries Designed to Be Functionally Diverse Recover Protein Binding Information More Efficiently Than Standard Structurally Diverse Libraries
Anna Carbery, R. Skyner, F. von Delft, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 16, pp. 11404-11413
Open Access | Times Cited: 27
ACFIS 2.0: an improved web-server for fragment-based drug discovery via a dynamic screening strategy
Xing-Xing Shi, Zhi-Zheng Wang, Fan Wang, et al.
Nucleic Acids Research (2023) Vol. 51, Iss. W1, pp. W25-W32
Open Access | Times Cited: 15
On the relevance of query definition in the performance of 3D ligand-based virtual screening
Javier Vázquez, Ricardo López García, Paula Llinares, et al.
Journal of Computer-Aided Molecular Design (2024) Vol. 38, Iss. 1
Open Access | Times Cited: 4
E-FTMap: A Protein Structure Based Pharmacophore Identification Server for Guiding Fragment Expansion
Omeir Khan, George Jones, Dima Kozakov, et al.
Journal of Molecular Biology (2025), pp. 168956-168956
Closed Access
Different applications and differentiated libraries for crystallographic fragment screening
Jessica E. Watt, Mathew P. Martin, Jane Endicott, et al.
Current Opinion in Structural Biology (2025) Vol. 90, pp. 102982-102982
Open Access
Expanding FTMap for Fragment-Based Identification of Pharmacophore Regions in Ligand Binding Sites
Omeir Khan, George Jones, Maria Lazou, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 6, pp. 2084-2100
Open Access | Times Cited: 3
Binding-Adaptive Diffusion Models for Structure-Based Drug Design
Zhilin Huang, L. Yang, Zaixi Zhang, et al.
Proceedings of the AAAI Conference on Artificial Intelligence (2024) Vol. 38, Iss. 11, pp. 12671-12679
Open Access | Times Cited: 3
Crystallographic fragment screening and deep mutational scanning of Zika virus NS2B-NS3 protease enable development of resistance-resilient inhibitors
F. von Delft, Xiaomin Ni, Riina Rautemaa‐Richardson, et al.
Research Square (Research Square) (2025)
Closed Access
Methylene Blue Is a Nonspecific Protein–Protein Interaction Inhibitor with Potential for Repurposing as an Antiviral for COVID-19
Sung-Ting Chuang, Henrietta Papp, Anett Kuczmog, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 5, pp. 621-621
Open Access | Times Cited: 14
An Update on the Current State of SARS-CoV-2 Mac1 Inhibitors
Joseph J. O’Connor, Dana Ferraris, Anthony R. Fehr
Pathogens (2023) Vol. 12, Iss. 10, pp. 1221-1221
Open Access | Times Cited: 7
Advanced technologies for screening and identifying covalent inhibitors
Yaolin Guo, Shuai Wen, Aiping Tong, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 178, pp. 117833-117833
Closed Access | Times Cited: 2
Identifying novel chemical matter against the Chikungunya virus nsP3 macrodomain through crystallographic fragment screening
Jasmin C. Aschenbrenner, André S. Godoy, M. Fairhead, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Using machine‐learning‐driven approaches to boost hot‐spot's knowledge
Nícia Rosário‐Ferreira, Alexandre M. J. J. Bonvin, Irina S. Moreira
Wiley Interdisciplinary Reviews Computational Molecular Science (2022) Vol. 12, Iss. 5
Open Access | Times Cited: 11
FastGrow: on-the-fly growing and its application to DYRK1A
Patrick Penner, Virginie Martiny, Louis Bellmann, et al.
Journal of Computer-Aided Molecular Design (2022) Vol. 36, Iss. 9, pp. 639-651
Open Access | Times Cited: 9
Emerging approaches to CDK inhibitor development, a structural perspective
Ian Hope, Jane Endicott, Jessica E. Watt
RSC Chemical Biology (2022) Vol. 4, Iss. 2, pp. 146-164
Open Access | Times Cited: 9
Natural Apocarotenoids and Their Synthetic Glycopeptide Conjugates Inhibit SARS-CoV-2 Replication
Ilona Bereczki, Henrietta Papp, Anett Kuczmog, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1111-1111
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top